4[4]Shorvon S,Stefan H.Overview of the safety of rewer antiEpitEpticdrugs[J].EpilEpsia,1997,38(supple 1):45-51.
二级参考文献12
1Glauser T A，Epilepsia，1999年，46卷，788页
2Faught E.Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience.Epilepsia, 1997, 38(Supple 1): S24-S27.
3Ben-Menachem E.Clinical Efficacy of topiramate as add-on therapy in refractory partial epilepsy: The European experience.Epilepsia, 1997, 38(Supple 1): S28-S30.
4Reife RA, Pledger GW.Topiramate as adjunctive therapy in refractory partial Epilepsy: pooled analysis of data from five double-blind, placebo-controlled trials.Epilepsia, 1997, 38(Supple 1): S31-S33.
5Rosenfeld WE, Sachdeo RC, Faught RE, et al.Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment.Epilepsia, 1997, 38(Supple 1):S34-S36.
6Biton V.Preliminary open-lable experience with topiramate in primary generalized seizures.Epilepsia, 1997, 38(Supple 1): S42-S44.
7Glauser TA, Cincinnati OH, Sachdeo RC, et al.Topiramate in Lennox-Gastaut syndrome, a double blind trial.Neurology,1997,48:1729.
8Gram L. Pharmacokinetics of new antiepileptic drugs.Epilepsia, 1996, 37(Supple 6): S12-S16.
9Shorvon S, Stefan H.Overview of the safety of newer antiepileptic drugs.Epilepsia, 1997, 38(Supple 1): S45-S51.
10Coulter DA, Sombati S, DeLorenzo RJ.Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons.Epilepsia, 1993, 34(Suppl 2): 123.
